Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: VNS PORTFOLIO follow-up
1
Dec 13, 2009 05:21AM
1
Dec 13, 2009 09:21AM
1
Dec 13, 2009 09:51AM

Dec 13, 2009 10:05AM

Dec 13, 2009 11:37AM
1
Dec 13, 2009 11:42AM
1
Dec 13, 2009 11:51AM
1
Dec 13, 2009 11:58AM
2
Dec 13, 2009 12:01PM

Dec 13, 2009 12:31PM
1
Dec 13, 2009 12:36PM

Dec 13, 2009 04:29PM

Dec 13, 2009 05:40PM

Dec 13, 2009 06:04PM
5
Dec 13, 2009 07:09PM

Dec 13, 2009 07:28PM
4
Dec 13, 2009 08:24PM
4
Dec 14, 2009 12:09AM
4
Dec 14, 2009 12:18AM

It would seem to me that with the VNS patent it is the industry that is in the real bind. The only way around the MMP has been patented by Mr. Moore, or TPL. The industry is definately going to have to pay us for past infringement if the modifications to the MMP claims are for clarity and not new claims. Since Mr. Henneman has worked on those modifications and is working also on the VNS patent if this new patent somehow prevents us from significant future claims a case of cohortion against Mr. Henneman could certainly be made by PTSC.That is why I don't know why they chose to use Mr. Henneman for the VSN patents. It would seem to open the door to possible future litigation. The last time two parties used the same attorney resulted in the splitting of the rights to the MMP. Where exactly we fit into this is not exactly clear to me. But my assumption that the reason the ASHM was being held in Chicago was because it was near Mr. Hennemans office would seem to be reasonable especially in the light of all of this.

AJMO with a great deal of confusion

I only bring all this up so others can at least look at the posibilities and investigate themselves. I could be way off base.


Dec 14, 2009 01:38AM
Share
New Message
Please login to post a reply